Osborne Partners Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.9M | Sell |
41,743
-2,223
| -5% | -$1.07M | 1.16% | 22 |
|
|
2026
Q1 | $21.6M | Buy |
43,966
+8,793
| +25% | +$4.77M | 1.14% | 24 |
|
|
2025
Q4 | $20.4M | Buy |
35,173
+2,565
| +8% | +$1.45M | 1.05% | 23 |
|
|
2025
Q3 | $15.8M | Buy |
32,608
+635
| +2% | +$296K | 0.8% | 36 |
|
|
2025
Q2 | $13M | Buy |
31,973
+3,199
| +11% | +$1.34M | 0.69% | 49 |
|
|
2025
Q1 | $14.3M | Sell |
28,774
-476
| -2% | -$258K | 0.83% | 36 |
|
|
2024
Q4 | $15.2M | Buy |
29,250
+697
| +2% | +$383K | 0.88% | 30 |
|
|
2024
Q3 | $17.7M | Sell |
28,553
-321
| -1% | -$190K | 1% | 25 |
|
|
2024
Q2 | $16M | Buy |
28,874
+8
| +0% | +$4.58K | 0.96% | 29 |
|
|
2024
Q1 | $16.8M | Buy |
28,866
+527
| +2% | +$296K | 1.03% | 26 |
|
|
2023
Q4 | $15M | Buy |
28,339
+849
| +3% | +$411K | 0.98% | 28 |
|
|
2023
Q3 | $13.9M | Buy |
27,490
+292
| +1% | +$156K | 1.03% | 28 |
|
|
2023
Q2 | $14.2M | Buy |
27,198
+643
| +2% | +$347K | 1.02% | 26 |
|
|
2023
Q1 | $15.3M | Buy |
26,555
+209
| +0.8% | +$118K | 1.12% | 24 |
|
|
2022
Q4 | $14.5M | Buy |
26,346
+273
| +1% | +$145K | 1.14% | 23 |
|
|
2022
Q3 | $13.2M | Buy |
26,073
+389
| +2% | +$218K | 1.11% | 23 |
|
|
2022
Q2 | $14M | Sell |
25,684
-892
| -3% | -$491K | 1.07% | 23 |
|
|
2022
Q1 | $15.7M | Buy |
26,576
+776
| +3% | +$446K | 1.16% | 25 |
|
|
2021
Q4 | $17.2M | Sell |
25,800
-26
| -0.1% | -$16.2K | 1.26% | 21 |
|
|
2021
Q3 | $14.8M | Buy |
25,826
+87
| +0.3% | +$47.8K | 1.19% | 23 |
|
|
2021
Q2 | $13M | Buy |
25,739
+479
| +2% | +$226K | 1.07% | 23 |
|
|
2021
Q1 | $11.5M | Buy |
25,260
+516
| +2% | +$246K | 1.05% | 25 |
|
|
2020
Q4 | $11.5M | Sell |
24,744
-7,768
| -24% | -$3.64M | 1.41% | 15 |
|
|
2020
Q3 | $14.4M | Sell |
32,512
-1,083
| -3% | -$447K | 2.89% | 3 |
|
|
2020
Q2 | $12.2M | Sell |
33,595
-1,130
| -3% | -$379K | 2.61% | 5 |
|
|
2020
Q1 | $9.85M | Buy |
34,725
+566
| +2% | +$178K | 2.56% | 8 |
|
|
2019
Q4 | $11.1M | Sell |
34,159
-3,133
| -8% | -$950K | 2.25% | 8 |
|
|
2019
Q3 | $10.9M | Sell |
37,292
-712
| -2% | -$204K | 2.18% | 10 |
|
|
2019
Q2 | $11.2M | Sell |
38,004
-628
| -2% | -$173K | 2.14% | 7 |
|
|
2019
Q1 | $10.6M | Sell |
38,632
-840
| -2% | -$209K | 2.06% | 9 |
|
|
2018
Q4 | $8.83M | Sell |
39,472
-447
| -1% | -$105K | 1.32% | 19 |
|
|
2018
Q3 | $9.74M | Sell |
39,919
-13,708
| -26% | -$3.15M | 1.25% | 21 |
|
|
2018
Q2 | $11.1M | Sell |
53,627
-4,307
| -7% | -$914K | 1.51% | 12 |
|
|
2018
Q1 | $12M | Sell |
57,934
-154
| -0.3% | -$32.3K | 1.65% | 12 |
|
|
2017
Q4 | $11M | Sell |
58,088
-2,548
| -4% | -$488K | 1.46% | 15 |
|
|
2017
Q3 | $11.5M | Sell |
60,636
-1,330
| -2% | -$241K | 1.57% | 13 |
|
|
2017
Q2 | $10.8M | Buy |
61,966
+1,299
| +2% | +$218K | 1.54% | 15 |
|
|
2017
Q1 | $9.32M | Sell |
60,667
-910
| -1% | -$139K | 1.33% | 19 |
|
|
2016
Q4 | $8.69M | Sell |
61,577
-705
| -1% | -$104K | 1.27% | 18 |
|
|
2016
Q3 | $9.91M | Sell |
62,282
-1,652
| -3% | -$255K | 1.48% | 18 |
|
|
2016
Q2 | $9.45M | Sell |
63,934
-4,470
| -7% | -$660K | 1.41% | 18 |
|
|
2016
Q1 | $9.69M | Sell |
68,404
-335
| -0.5% | -$44.9K | 1.42% | 17 |
|
|
2015
Q4 | $9.75M | Sell |
68,739
-1,380
| -2% | -$184K | 1.42% | 19 |
|
|
2015
Q3 | $8.57M | Buy |
70,119
+691
| +1% | +$90K | 1.26% | 27 |
|
|
2015
Q2 | $9.01M | Sell |
69,428
-1,215
| -2% | -$158K | 1.21% | 27 |
|
|
2015
Q1 | $9.49M | Sell |
70,643
-7,725
| -10% | -$996K | 1.25% | 26 |
|
|
2014
Q4 | $9.82M | Buy |
78,368
+1,570
| +2% | +$191K | 1.19% | 30 |
|
|
2014
Q3 | $9.35M | Sell |
76,798
-450
| -0.6% | -$54.7K | 1.21% | 29 |
|
|
2014
Q2 | $9.12M | Buy |
77,248
+804
| +1% | +$94.6K | 1.17% | 29 |
|
|
2014
Q1 | $9.19M | Buy |
76,444
+68
| +0.1% | +$8.09K | 1.2% | 30 |
|
|
2013
Q4 | $8.5M | Sell |
76,376
-599
| -0.8% | -$59.6K | 1.11% | 34 |
|
|
2013
Q3 | $7.09M | Sell |
76,975
-805
| -1% | -$72.8K | 0.99% | 40 |
|
|
2013
Q2 | $6.58M | Buy |
+77,780
| New | +$6.47M | 0.94% | 41 |
|
Other funds holding TMO
Osborne Partners Capital Management's TMO Position: Q2 2026 in Review
Osborne Partners Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 5.1% in Q2 2026, selling an estimated $1.07M and leaving 41,743 shares worth $20.9M. The position accounts for 1.16% of the portfolio, ranked #22.
Osborne Partners Capital Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.6M in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Osborne Partners Capital Management held 41,743 shares of Thermo Fisher Scientific worth $20.9M as of Q2 2026.
- Osborne Partners Capital Management sold 2,223 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.07M.
- Thermo Fisher Scientific made up 1.16% of Osborne Partners Capital Management's portfolio in Q2 2026, its #22 holding.
- Osborne Partners Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Osborne Partners Capital Management's Thermo Fisher Scientific position peaked at $21.6M in Q1 2026.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Osborne Partners Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.